Business

Claude View

Know the Business — Nomad Foods (NOMD)

Bottom line. Nomad Foods is Europe's #1 branded frozen-food roll-up: ~17-18% share of the savory frozen category across ~16 countries, built by stitching together 80-to-100-year-old local brands (Birds Eye in UK/Ireland, iglo in Germany, Findus in the Nordics/Italy, Ledo/Frikom in the Balkans). The economic engine is shelf-space + brand heritage in a slow-growth (~1% category) market — which means free cash flow is reliable but organic growth is not. The market looks like it's pricing in secular decline (EV/EBITDA ~8x, P/B 0.48x, FCF yield >20%), while the real risk is something subtler: a three-year stretch of flat-to-down organic volumes, a margin compression cycle, and a new CEO (Dominic Brisby, Dec-2025) publicly calling 2026 a "transition year." All figures are in USD; Nomad reports in EUR but trades as an NYSE ADR.

1. How This Business Actually Works

One-line mental model: Nomad rents roughly a fifth of Europe's frozen-aisle freezer space, stocked with brands consumers' grandparents grew up with, and collects a mid-single-digit net margin on ~$3.6 billion of sticky repeat purchases.

What actually drives the P&L. About 73% of every dollar of revenue goes straight to cost of sales — fish, vegetables, poultry, packaging, energy, and third-party logistics. The next ~14% is SG&A plus A&P (advertising & promotion). That leaves ~13% for Adjusted EBITDA, which steps down to ~8-9% free cash flow after capex (~3% of sales), interest on ~$2.7B of term loans (~$212M interest expense, interest coverage just 1.8x), and taxes. The incremental dollar of profit comes from three places: procurement savings on fish and vegetables, pricing power pushed through to retailers, and mix shift into higher-margin ready meals, pizza, and ice cream (via the Ledo/Frikom acquisition in the Balkans).

The bottleneck is not a factory — it's the freezer. European grocers allocate a fixed amount of frozen-aisle real estate, so competition isn't "grow the aisle" but "win more of it." This is why Nomad defines its job as defending two metrics: market share in ~16 countries and retail sell-out (point-of-sale units through scanner data). FY25 retail sell-out grew +0.4% — but shipments were -1.9% organic, meaning retailers destocked. That's the Q1'25 "retailer destocking" story in one line.

Pricing power is real but asymmetric. During 2022-2023 Nomad pushed double-digit price increases to offset fish and energy inflation — gross margin held. Going the other way, when costs fall, retailers (Tesco, Rewe, Lidl, Aldi) demand givebacks. FY25 gross margin compressed 210 bps on "supply chain inflation" and higher A&P reinvestment, showing the price/margin trade-off cuts both ways.

2. The Playing Field

Nomad is the only listed pure-play European frozen leader; the public food-staples peer set below is the only comparable group but none of them are a true analog (closest is privately-held McCain Foods, which is not public). NOMD trades at the deepest discount of this set — a P/B of 0.48x and EV/EBITDA of 8.6x on a tape where peers are either cheaper because they're impaired (CAG, SJM) or more expensive because they're profitable (GIS, K, CPB).

What the peer table reveals.

The margin gap is real and structural. Nomad's 27% gross margin is the lowest in the set. Kellanova, SJM, and GIS clear 33-35%. Why? Nomad's mix is heavier in commoditized center-plate proteins (fish, poultry, meat — a large share of revenue led by fish fingers and fillets) that carry lower markups than salty snacks, cereal, or coffee concentrates. European grocers also run harder discount formats (Lidl, Aldi, Netto) that apply more private-label pressure than US retailers.

Leverage is the other structural fact. NOMD's debt-to-equity of 1.54x is among the highest on the board, tied with Kellanova, reflecting the original 2015-2016 LBO-style rollup history (acquiring iglo from Permira for ~€2.6B). Interest coverage fell to 1.8x in FY25 (from 3.5x in FY24) — the refinancing of the term loans in Q4'25 triggered a €57M one-time loss and pushed interest expense up sharply.

The valuation gap is the prize. At 8.6x EV/EBITDA and 0.48x book value, Nomad trades like Conagra (which is actively impaired) rather than like GIS/K/CPB (profitable despite volume headwinds). If you believe Nomad's brands deserve any meaningful equity premium, the gap is the mispricing — if you don't, the gap is deserved.

3. Is This Business Cyclical?

One-line answer: No in the classical sense (GDP/recession), but yes in three under-appreciated ways — commodity input cycles, retailer destocking cycles, and currency cycles. Demand itself is close to counter-cyclical: during COVID, frozen volumes spiked as in-home meals surged; Nomad explicitly notes consumers "trade into frozen to save money" during inflation scares.

The three real cycles.

Commodity input cycle. In 2022-2023, Nomad faced ~15% input inflation on fish, vegetables, energy, and packaging. Response: double-digit list-price increases that restored gross margin. When commodity prices normalized in 2024, retailers clawed back some of that pricing — FY25 gross margin fell 210 bps, and "supply chain inflation" is again cited as the headwind.

Retailer destocking cycle. European grocers actively manage freezer inventory. In Q1'25, retailers destocked in response to prior over-ordering — organic revenue fell -3.6% while retail sell-out was actually positive. This creates quarterly volatility divorced from true consumer demand.

Currency cycle. Nomad reports in EUR but trades in USD. The stock price in USD absorbs ~+/-10% EUR-USD moves independent of fundamentals. FY25 translational FX was a +0.3% tailwind; other years it has been a headwind.

FY24 peaked near structural best; FY25 compressed and 2026 guidance implies further decline — we are heading back toward the 2022 trough. The bull case is that by H2'26 the company laps the worst of this and margins reset.

4. The Metrics That Actually Matter

Forget P/E and dividend yield for this name. These five metrics tell you whether Nomad is winning or losing.

Why these beat the "standard" ratios.

Organic Revenue Growth strips out FX translation (meaningful for a EUR reporter with a USD listing) and M&A (Fortenova 2021 created a 2-year optical tailwind). It is the only clean top-line number.

Retail Sell-Out is the leading indicator. Shipments to retailers can oscillate on inventory timing, but scanner-based sell-out reflects what consumers actually buy. When sell-out exceeds shipments, retailers are destocking (bearish near-term, neutral long-term). When sell-out trails shipments, retailers are loading (bullish near-term but a coming payback). FY25 had sell-out above shipments — the setup is mechanically constructive for 2026 if consumer demand holds.

Adjusted EBITDA margin captures whether the company is winning on procurement, A&P efficiency, and pricing simultaneously. A 100 bps move on ~$3.6B of revenue is ~$36M of EBITDA — roughly a 6% EPS swing.

Adjusted FCF Conversion (Adj FCF ÷ Adj Profit) is how honest the earnings are. Nomad printed 73% in 2025 (reasonable) and is guiding 90%+ for 2026 — a reassuring commitment but a big number, and it depends heavily on working-capital release.

Leverage. With ~$2.7B of total debt against ~$600M of LTM Adj EBITDA, gross leverage is in the 4.0-4.5x zone. Rising interest expense (1.8x coverage in 2025 vs 3.5x in 2024) makes this the single biggest source of equity risk. Covenants aren't tight yet, but another year of EBITDA decline changes the conversation.

ROIC of ~6% sits below the company's likely cost of capital — a direct consequence of paying 10x+ EBITDA for acquisitions (iglo in 2015, Goodfella's in 2018, Fortenova in 2021) and carrying ~$2.1B of goodwill and ~$2.5B of intangibles. The thesis that NOMD is structurally undervalued requires believing either (a) ROIC expands materially through operating leverage, or (b) the goodwill is real (brand equity) and the accounting ROIC understates true economic returns.

5. What I'd Tell a Young Analyst

Watch retail sell-out, not reported revenue. The shipment vs sell-out gap is the single cleanest leading indicator on this name. Q4'25 sell-out was +0.7% with shipments down -1.3% — that's the mechanical setup for a volume reversion in 2026 if it holds.

The bull case is margin + leverage, not growth. Don't model Nomad as a growth story — category growth is ~1% and Nomad is losing share at the moment. The bull case is: ~$600M Adj EBITDA recovers toward $650-680M by 2027 as cost savings compound, debt drops from the ~$310M/year capital return pace, and the multiple rerates from 8.5x to 10x. That is a double without ever needing organic growth above +2%.

The bear case is the 2026 transition year extending. New CEO Dominic Brisby started Dec-2025 and immediately called 2026 "a transition year." CEOs who publicly lower the bar in month two usually take 18-24 months to stabilize. If organic revenue is still negative entering 2027, the leverage math gets ugly fast at 1.8x interest coverage.

Ignore dividend yield headlines — watch capital return. Nomad paid a cash dividend for the first time in 2024. Total FY25 capital return was €287M (~$310M), a 38% increase on 2024. The real signal is the pace of share repurchases — FY25 ended at 142.4M basic shares, down 9% YoY. If management sustains that pace, EPS grows even with flat EBITDA.

The thing the market is missing — probably. NOMD trades at 0.48x book. That means if the ~$2.1B of goodwill and ~$2.5B of intangibles are worth anything close to what's on the balance sheet, equity is worth multiples of today's price. The market is saying those assets are impaired. If Q4'25 sell-out acceleration continues into H1'26, that thesis breaks.

The thing I'd genuinely worry about. Three consecutive years of negative organic volumes in a supposedly defensive category. That's not a cyclical blip — it's a share-loss story somewhere (likely to private label in discount channels in Germany/UK). If the new CEO can't produce positive volume growth by late 2026, this is a value trap, not a deep-value idea.